pillbase.ru

INVOKAMET XR

Active substance: CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE

TABLET, FILM COATED, EXTENDED RELEASE · CANAGLIFLOZIN 50 mg/1, METFORMIN HYDROCHLORIDE 1000 mg/1

United StatesActive

Marketing holder: Janssen Pharmaceuticals, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Products containing canagliflozin in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
EU 2
  • Invokana
    canagliflozin
    EMEA/H/C/002649
    Janssen-Cilag International NV
  • Vokanamet
    canagliflozin, metformin hydrochloride
    EMEA/H/C/002656
    Janssen-Cilag International NV
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-6c5b-7e25-a085-df4b8cd9d822,01a1208c-773f-7cc7-a693-6c227aca8302,01a1208e-587a-7814-a6e1-140c5ae75adc,01a12091-ae05-75d8-b3dc-2ff51dce0c6b,01a12093-8a1e-71ae-a54a-e1f0bfdabc40;count=7 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
50458-941
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 50458-941 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 50458-941 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 50458-941 · Verified 2026-10-09 · open in source
  • ingredients.1 · openFDA NDC · 50458-941 · Verified 2026-10-09 · open in source